Estradiol Monitoring and Management in HRT‑FET Cycles

Target Estradiol Dosing Strategies

A 100 µg transdermal 17β‑estradiol patch or a 2 mg oral estradiol dose typically achieves physiological serum estradiol concentrations suitable for HRT‑FET preparation. 1
Transdermal estradiol delivery is preferred over oral administration because it bypasses hepatic first‑pass metabolism and reduces the risk of thromboembolic events. 3

Estradiol < 200 pg/mL: Increase the estradiol dose, re‑measure serum levels after 3–5 days, and defer embryo transfer until the target range is reached. 3
Estradiol 200–500 pg/mL: Proceed with progesterone supplementation and schedule embryo transfer as planned. 1
Estradiol > 500 pg/mL: Do not initiate progesterone or transfer; reduce the estradiol dose, re‑check levels, and restart cycle preparation once the level falls within the target range. 1
If estradiol remains above target despite dose adjustments, consider switching from oral to transdermal estradiol formulation. 4

Within the therapeutic estradiol range, serum estradiol concentration does not correlate significantly with endometrial thickness; therefore, ultrasound evaluation of the lining remains essential for confirming adequate endometrial development. 3

Certain patients may need higher estradiol doses than those commonly used for standard menopausal hormone therapy to achieve the desired serum levels for HRT‑FET cycles. 1

Once appropriate estradiol levels are confirmed, administer micronized progesterone 100–200 mg daily for 12–14 days to protect the endometrium and support implantation. [4][5]